Tower Research Capital LLC TRC Boosts Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Tower Research Capital LLC TRC lifted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 104.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 38,136 shares of the company's stock after purchasing an additional 19,467 shares during the period. Tower Research Capital LLC TRC's holdings in GE HealthCare Technologies were worth $2,981,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of GEHC. Cherry Creek Investment Advisors Inc. raised its position in shares of GE HealthCare Technologies by 0.3% during the fourth quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company's stock worth $2,920,000 after acquiring an additional 114 shares during the last quarter. Independence Bank of Kentucky raised its holdings in GE HealthCare Technologies by 6.0% during the 4th quarter. Independence Bank of Kentucky now owns 2,018 shares of the company's stock worth $158,000 after purchasing an additional 114 shares during the last quarter. Haverford Trust Co lifted its position in shares of GE HealthCare Technologies by 2.4% in the 4th quarter. Haverford Trust Co now owns 4,896 shares of the company's stock worth $383,000 after purchasing an additional 115 shares during the period. Tandem Capital Management Corp ADV boosted its stake in shares of GE HealthCare Technologies by 0.4% in the 4th quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company's stock valued at $2,205,000 after purchasing an additional 118 shares during the last quarter. Finally, Arcus Capital Partners LLC increased its position in shares of GE HealthCare Technologies by 3.0% during the fourth quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company's stock worth $322,000 after buying an additional 119 shares during the period. Institutional investors own 82.06% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently commented on the company. Piper Sandler cut their target price on GE HealthCare Technologies from $104.00 to $88.00 and set an "overweight" rating on the stock in a research report on Wednesday. Citigroup raised their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research report on Thursday, February 13th. Wells Fargo & Company lifted their price objective on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research note on Friday, February 14th. BTIG Research set a $95.00 target price on shares of GE HealthCare Technologies and gave the stock a "buy" rating in a research note on Monday, April 14th. Finally, The Goldman Sachs Group raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and lifted their price target for the company from $85.00 to $100.00 in a research note on Tuesday, March 11th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $96.50.

GE HealthCare Technologies Stock Performance

GE HealthCare Technologies stock traded up $1.34 during trading on Friday, hitting $68.42. The stock had a trading volume of 5,508,561 shares, compared to its average volume of 3,250,958. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock's 50 day moving average is $77.07 and its two-hundred day moving average is $82.34. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The stock has a market cap of $31.33 billion, a price-to-earnings ratio of 15.80, a price-to-earnings-growth ratio of 3.19 and a beta of 1.14.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. As a group, analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 annualized dividend and a dividend yield of 0.20%. GE HealthCare Technologies's dividend payout ratio is currently 3.23%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.